Register entryShortage reported
Long Grove Pharmaceuticals, LLC
- Registered sites
- 0
- Drug products
- 14
- Live patents
- 21
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Alert
Products in shortage
1| Drug | Presentation | Availability |
|---|---|---|
| Sodium Bicarbonate Injection | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3) | Available |
Exclusivity
Patents
21Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | Jan 2038 |
Catalogue
Marketed products
14Showing 14 of 14.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| AK-FLUOR | fluorescein | INJECTION | NDA |
| Carboprost Tromethamine | Carboprost Tromethamine | INJECTION | ANDA |
| Dalbavancin | dalbavancin hydrochloride | INJECTION, POWDER, FOR SOLUTION | ANDA |
| Eribulin Mesylate | Eribulin Mesylate | SOLUTION | ANDA |
| Methadone Hydrochloride | Methadone Hydrochloride | INJECTION | ANDA |
| Norepinephrine | Norepinephrine Bitartrate | SOLUTION | NDA |
| Norepinephrine | Norepinephrine Bitartrate | SOLUTION | NDA |
| Norepinephrine | Norepinephrine Bitartrate | SOLUTION | NDA |
| SODIUM BICARBONATE | sodium bicarbonate injection, | SOLUTION | ANDA |
| Triamcinolone Acetonide | Triamcinolone Acetonide | SUSPENSION | ANDA |
| Triamcinolone Acetonide | Triamcinolone Acetonide | SUSPENSION | ANDA |
| Triamcinolone Acetonide | Triamcinolone Acetonide | SUSPENSION | ANDA |
| Vasopressin in 0.9% Sodium Chloride | Vasopressin | SOLUTION | NDA |
| Vasopressin in 0.9% Sodium Chloride | Vasopressin | SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.